Postgrad LIVE! Study Fairs

Southampton | Bristol

Nottingham Trent University Featured PhD Programmes
University of Glasgow Featured PhD Programmes
Imperial College London Featured PhD Programmes
Anglia Ruskin University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes

Structure guided inhibitors design of human Mitochondrial Thymidine Kinase (TK2)

This project is no longer listed in the FindAPhD
database and may not be available.

Click here to search the FindAPhD database
for PhD studentship opportunities
  • Full or part time
    Dr Y Jin
  • Application Deadline
    Friday, March 15, 2019

Project Description

Background

Mitochondrial Thymidine Kinase 2 (TK2) catalyses transfer of a γ-phosphate group from ATP to the 5′-hydroxyl group of thymidine, deoxycytidine, or deoxyuridine to form their 5’-mono-phosphates. Deficiency in TK2 activity due to genetic mutation causes devastating mitochondrial DNA depletion syndrome (MDS), affecting mainly liver and skeletal muscle. Per contra, active TK2 in human tumour cells can reduce effectiveness of the anti-cancer drug gemcitabine by phosphorylating deoxycytidine which eventually leads to the generation of dCTP. TK2 is thus proven to be a drug target for development of both activators and inhibitors.

Despite the importance of TK2, there is a fundamental lack of structural information about TK2, which is a real barrier to a clear understanding of its biological function and targeted drug design.

Aims and methods

We will use a powerful set of chembiological techniques, namely NMR and x-ray crystallography, in combination with the utilisation of inorganic and synthetic bisubstrate analogues to perform functional and structural characterization of TK2, and thereby significantly advance knowledge of this drugable mitochondrial enzyme.

The project will offer the candidate the necessary and comprehensive training in molecular biology, biochemistry, structural biology, and drug discovery within 3.5 years. It is particular suitable for candidate who has strong synthetic chemistry background wanting to move into the field of drug discovery.

Academic criteria

Applicants with at least a Second Class degree in Chemistry, Pharmaceutical Sciences, Biochemistry, or related disciplines will be considered if they also have a master’s degree. Candidates with strong maths and physics at UK A levels are particularly favourable. Applicants with a minimum Upper Second Class degree and significant relevant non-academic experience are also encouraged to apply.

Papers to read: Current Pharmaceutical Design, 2012, 18, 2981-2994


Supervisor: Dr Yi Jin https://www.cardiff.ac.uk/people/view/742977-jin-yi

Start date: 1 April 2019

Funding Notes

Tuition fee support - Full UK/EU tuition fees

Maintenance stipend - Doctoral stipend matching UK Research Council National Minimum

Additional funding offered
Additional funding is available over the course of the programme and will cover costs such as research consumables, training, conferences and travel.

Residency - UK Research Council eligibility conditions apply. For more details view our website https://www.cardiff.ac.uk/study/postgraduate/funding/view/epsrc-doctoral-training-partnership-phd-in-chemistry

How good is research at Cardiff University in Chemistry?

FTE Category A staff submitted: 23.00

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities


FindAPhD. Copyright 2005-2019
All rights reserved.